Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Lunch and Poster Display session

275P - Clinical and socioeconomic risk factors of prolonged opioid use after breast cancer: A Danish population-based study

Date

16 May 2024

Session

Lunch and Poster Display session

Presenters

Kirsten Woolpert

Citation

Annals of Oncology (2024) 9 (suppl_4): 1-12. 10.1016/esmoop/esmoop103324

Authors

K.M. Woolpert1, A. Kjærsgaard2, H.T. Sørensen3, D. Cronin-Fenton2

Author affiliations

  • 1 Aarhus Universitet, Aarhus/DK
  • 2 Aarhus University and Aarhus University Hospital, Aarhus N/DK
  • 3 Aarhus University and Aarhus University Hospital, 8200 - Aarhus N/DK

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 275P

Background

Women with breast cancer are often prescribed opioids for pain-relief post-operatively and/or during treatment. Opioids have a high risk of leading to a substance use disorder, and prolonged use can result in overdose, drug dependence, hospitalization, and mortality. We aimed to determine risk factors for prolonged opioid use or continued opioid use for more than one year after breast cancer diagnosis.

Methods

We identified women diagnosed with stage I-III breast cancer from the Danish Cancer Registry (1997–2020). We excluded women who were prescribed an opioid in the year before breast cancer diagnosis. Prolonged opioid users were defined as women who received one or more opioid prescriptions 0-12 months after diagnosis and two or more prescriptions 12-24 months after diagnosis. We linked patients to several population-based registries to obtain information on risk factors as of the diagnosis date. Multivariable logistic models adjusted for covariates identified from directed acyclic graphs were used to evaluate odds ratios (ORs) and 95% confidence intervals (95% CIs).

Results

Among 75, 618 non-prevalent opioid users diagnosed with breast cancer during the study period, 2, 534 (3.4%) became prolonged users. Prolonged use was more likely in earlier years of the study period (1997-2008 vs. 2009-2020, OR: 1.41, 95% CI: 1.30, 1.53). Women with stage III disease (vs. stage I or II) had higher risk of prolonged use (OR: 2.00, 95% CI: 1.81, 2.22). Unmarried women (vs. married) also had a higher risk of prolonged use (OR: 1.29, 95% CI: 1.19, 1.41). Compared with college-educated women, women with a high-school education were more likely (OR: 1.37, 95% CI, 1.25, 1.51) and women with a tertiary-level education were less likely (OR: 0.79, 95% CI, 0.70, 0.90) to have prolonged opioid use.

Conclusions

Women with higher-stage disease were more likely to be prolonged users of opioids, raising the possibility of long-term adverse treatment effects. Socioeconomically vulnerable patients and women who may lack at-home support also appeared to be at increased risk. It is important for healthcare providers to consider how to best manage long-term pain and potential addictions in these at-risk patient groups.

Legal entity responsible for the study

Aarhus University.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.